| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/1991 | WO1991010731A1 Method of preparing lysozyme dimers |
| 07/25/1991 | WO1991010730A1 Method of preparing ribonuclease dimers |
| 07/25/1991 | WO1991010727A1 Inhibitors of cell regulatory factors |
| 07/25/1991 | WO1991010722A2 Chimeric immunoglobulin for cd4 receptors |
| 07/25/1991 | WO1991010682A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
| 07/25/1991 | WO1991010680A1 Tumor killing effects of enterotoxins and related compounds |
| 07/25/1991 | WO1991010679A2 RENIN INHIBITING PEPTIDES HAVING AN alpha -HETEROATOM AMINO ACID AT THE P3 POSITION |
| 07/25/1991 | WO1991010671A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/25/1991 | WO1991010453A1 Vector with multiple target response elements affecting gene expression |
| 07/25/1991 | WO1991010447A1 Tissue plasminogen activator |
| 07/25/1991 | WO1991010443A1 Immunosuppressive compositions and methods of use |
| 07/25/1991 | WO1991010442A1 Hiv protease inhibitors |
| 07/25/1991 | WO1991010441A1 Polypeptide and amino acid based composition |
| 07/25/1991 | WO1991010439A1 Stable injectible solutions for factor viii and factor ix |
| 07/25/1991 | WO1991010438A1 Soluble t-cell antigen receptor chimeric antigens |
| 07/25/1991 | WO1991010437A1 Methods of enhancing wound healing and tissue repair |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | WO1991010369A1 Method for preparing an enzymatic hydrolyzate |
| 07/25/1991 | WO1991010348A2 Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess |
| 07/25/1991 | DE4001236A1 New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC |
| 07/25/1991 | CA2034826A1 Process for the production of thrombin and high purity thrombin preparations thereby obtained |
| 07/25/1991 | CA2034737A1 Pharmaceutical preparation for the maturation of prothymocytes |
| 07/24/1991 | EP0438312A2 Recombinant human anti-CD18 antibodies |
| 07/24/1991 | EP0438311A2 Di- and tripeptide renin inhibitors |
| 07/24/1991 | EP0438259A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/24/1991 | EP0438234A1 Antithrombin solution and use thereof |
| 07/24/1991 | EP0438233A2 Orally active renin inhibitors |
| 07/24/1991 | EP0438196A1 A method of preparing a fibrinogen concentrate from blood plasma, a device for carrying out said method, and a method of preparing fibrinogen from said concentrate |
| 07/24/1991 | EP0438147A2 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/24/1991 | EP0438146A2 Interleukin-1-beta for treating ulcers |
| 07/24/1991 | EP0437958A1 Method for heat treatment of lactoferrin without losing physiological activities thereof |
| 07/24/1991 | EP0437846A2 Solutions of decaplanin salts, their preparation and their use, as well as crystalline decaplanin salts, their preparation and their use |
| 07/24/1991 | EP0437729A2 New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses |
| 07/24/1991 | EP0437622A1 Stable motilin preparation |
| 07/24/1991 | EP0437621A1 Aqueous solution of motilin |
| 07/24/1991 | EP0437610A1 Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide |
| 07/24/1991 | EP0437604A1 Recombinant poxvirus and streptococcal m protein vaccine |
| 07/24/1991 | EP0437599A1 Cell lineages expressing a biologically active ix factor |
| 07/24/1991 | EP0437577A1 Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes |
| 07/24/1991 | EP0437556A1 Substitution analogues of magainin peptides. |
| 07/24/1991 | EP0437547A1 Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family |
| 07/24/1991 | EP0437505A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 07/24/1991 | EP0437478A1 Cyclodextrin-peptide complexes. |
| 07/24/1991 | EP0437450A1 Method and composition for preventing conception |
| 07/24/1991 | EP0437427A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
| 07/24/1991 | EP0265468B1 Dispersion of lipidic spherules |
| 07/24/1991 | CN1053265A Human c3b/c4b receptor (cr1) |
| 07/24/1991 | CA2033682A1 3-l-(5-thioxo-l-propyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them |
| 07/24/1991 | CA2008519A1 Method for the inhibition of cell-cell and cell-substratum interactions by the blocking of carbohydrate-carbohydrate interactions |
| 07/24/1991 | CA2008438A1 Peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same |
| 07/23/1991 | US5034510 Polypeptides as antibacterial agents |
| 07/23/1991 | US5034376 Treatment of hypertension |
| 07/23/1991 | US5034375 Process of wound healing using PDGF and EGF |
| 07/23/1991 | US5034225 Stabilized human tissue plasminogen activator compositions |
| 07/23/1991 | US5034223 Antitumor agents |
| 07/23/1991 | CA2034516A1 Transdermal administration of zwitterionic drugs |
| 07/23/1991 | CA1286848C METHOD OF PREPARING .alpha.-1-PROTEINASE INHIBITOR |
| 07/23/1991 | CA1286696C Automatic process for purifying physiologically active substance, apparatus for the same, and carrier with proteinaceous ligand fixed theretoto be used for the same |
| 07/23/1991 | CA1286619C Cell line producing aids viral antigens without producing infectious virus particles |
| 07/23/1991 | CA1286607C Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents |
| 07/20/1991 | WO1991010685A1 Cytotoxic cell-specific protease-related molecules and methods |
| 07/20/1991 | WO1991010448A1 A cell surface antigen associated with cellular apoptosis |
| 07/20/1991 | CA2074081A1 Cytotoxic cell-specific protease-related molecules and methods |
| 07/20/1991 | CA2034593A1 Recombinant human anti-cd18 antibodies |
| 07/20/1991 | CA2034574A1 Recombinant human anti-cd18 antibodies |
| 07/20/1991 | CA2034524A1 Di- and tripeptide renin inhibitors containing non-peptidal conformationally-constrained tripeptide mimic for leu10-val11-ile12 |
| 07/20/1991 | CA2034520A1 Pharmaceutical composition for protecting the gastroduodenal mucosa |
| 07/20/1991 | CA2034519A1 Pharmaceutical compositions and dosage forms for the oral administration of calcitonin |
| 07/20/1991 | CA2033680A1 Administration method of antithrombin |
| 07/19/1991 | CA2034315A1 Orally active renin inhibitors |
| 07/18/1991 | DE4100418A1 Agent for stopping smoking - contg. soya bean protein |
| 07/17/1991 | WO1991010742A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/17/1991 | EP0437367A2 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
| 07/17/1991 | EP0437346A1 Anti-viral fraction of aqueous Lentinus edodes extract |
| 07/17/1991 | EP0437281A1 Composition comprising acidic fibroblast growth factor (aFGF) |
| 07/17/1991 | EP0437244A1 Glidobactin PF-1 peptide antitumor antibiotics |
| 07/17/1991 | EP0436737A1 Phospholipase a 2? inhibiting protein originating in inflamed region, production thereof, and gene therefor |
| 07/17/1991 | EP0436648A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 07/17/1991 | EP0436634A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| 07/17/1991 | EP0436626A1 THE RECEPTOR BINDING REGION OF EBVgp350 |
| 07/17/1991 | EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 07/17/1991 | EP0436611A1 Compound and method for the retardation of collagen cross-linking |
| 07/17/1991 | CN1053010A Pharmaceutical preparation |
| 07/17/1991 | CA2073060A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/16/1991 | US5032608 Method and substrate composition for treating atherosclerosis |
| 07/16/1991 | US5032577 Peptidylaminodiols |
| 07/16/1991 | US5032575 Epidermal growth factor or homolog thereof |
| 07/16/1991 | US5032574 Novel antimicrobial peptide |
| 07/16/1991 | US5032573 Homologs of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
| 07/16/1991 | US5032507 Potentiation of erythropoiesis |
| 07/16/1991 | US5032405 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 07/16/1991 | US5032396 Interleukin-7 |
| 07/16/1991 | US5032395 Growth stimulants, interleukin-3 |
| 07/16/1991 | US5032394 Ethylene oxide-propylene oxide copolymer |
| 07/16/1991 | CA1286286C Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
| 07/16/1991 | CA1286224C Use of human growth hormone for the treatment of intoxicated individuals |
| 07/13/1991 | WO1991010741A1 Generation of xenogeneic antibodies |
| 07/13/1991 | WO1991010424A1 Method of inhibiting angiogenesis of tumors |
| 07/13/1991 | CA2050918A1 Generation of xenogeneic antibodies |
| 07/13/1991 | CA2050290A1 Method of inhibiting angiogenesis of tumors |